Skip to main content
Premium Trial:

Request an Annual Quote

Thompson Street Capital to Acquire Transnetyx

NEW YORK (GenomeWeb) – Transnetyx announced on Tuesday that it will be acquired by private equity firm Thompson Street Capital Partners.

Transnetyx provides automated genotyping services for the research community. Its system detects transgenic, knock-out, knock-in, SNP, and CRISPR mutations in mouse, zebrafish, rabbit, ferret, goat, and rat lines.

Under the terms of the deal, Thompson Street will acquire YX Genomics Holding, the holding company of Transnetyx, lab management services firm YX Services, and robotics company RobotYX. Additional terms were not disclosed.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.